<DOC>
	<DOCNO>NCT02828124</DOCNO>
	<brief_summary>A Study Evaluate Safety Tolerability BMS-986183 Patients Liver Cancer</brief_summary>
	<brief_title>A Study BMS-986183 Subjects With Advanced Hepatocellular Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>For information regard BristolMyers Squibb Clinical Trial participation , please visit www.BMSStudyConnect.com Must advance liver cancer treat surgery local method Liver cancer confirm microscopic examination tissue Liver disease classify ' A ' standard method call ChildPugh score Daily living ability classify ' 0 1 ' standard method Eastern Cooperative Oncology Group ( ECOG ) Women must use contraception Prior liver transplant Increase blood pressure vein enter liver Cancer spread brain layer tissue cover brain spinal cord Disease heart blood vessel around heart Active cancer within last 2 year No 2 prior systemic treatment investigational agent except PD1/PDL1 Ipilimumab ( Part 2 ) Currently antiplatelet anticoagulation therapy Radiotherapy within 4 week treatment Other protocol define inclusion/exclusion criterion could apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>